Coronary artery calcium (CAC) screening is the best non-invasive tool for measuring the risk of cardiovascular disease in asymptomatic patients with diabetes, according to a state-of-the-art paper from ACC’s Imaging Council published Feb. 1 in JACC: Cardiovascular Imaging. According to the authors, patients with type-2 diabetes have higher amounts of CAC than nondiabetic patients, but a high proportion of adults with diabetes have a CAC score of 0 or very low. They explain that CAC provides strong risk stratification of these patients, with an increase in mortality for each increase in CAC score category. Read more on ACC.org.